Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identification of an epithelial-specific enhancer regulating ESX expression.

Richard M Neve1, Hema Parmar, Cliff Amend

  • 1Cancer Research Institute, University of California San Francisco, Box 0808, San Francisco, CA 94143-0808, USA. rmneve@lbl.gov

Gene
|November 26, 2005
PubMed
Summary

Researchers identified a specific DNA enhancer sequence (EES) responsible for the epithelial-specific expression of the ESX transcription factor. This finding offers insights into epithelial differentiation and breast cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-propargylglycine restores survival by preventing calcium oxalate stone formation, tubular injury, and kidney dysfunction in a lethal mouse model of primary hyperoxaluria type 2.

Kidney international·2026
Same author

Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.

International journal of cancer·2025
Same author

Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation.

Structure (London, England : 1993)·2025
Same author

Protocol for obtaining cancer type and subtype predictions using subSCOPE.

STAR protocols·2025
Same author

Protocol for assessing distances in pathway space for classifier feature sets from machine learning methods.

STAR protocols·2025
Same author

Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenase.

Archives of biochemistry and biophysics·2025

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The Ets transcription factor, ESX, plays a crucial role in epithelial differentiation and is implicated in cancer development.
  • ESX exhibits a unique expression pattern restricted to epithelial cells, suggesting a specific regulatory mechanism.

Purpose of the Study:

  • To elucidate the genetic basis underlying the epithelial-specific expression of the ESX transcription factor.
  • To identify regulatory elements controlling ESX gene transcription in epithelial cells.

Main Methods:

  • Identification and characterization of an enhancer sequence (EES) located upstream of the ESX proximal promoter.
  • Functional analysis of the EES region using deletion assays to assess its impact on ESX transcription.
  • Electrophoretic mobility shift assays (EMSA) to identify and characterize EES-binding proteins (EBC).

Related Experiment Videos

Main Results:

  • A 30bp ESX enhancer sequence (EES) was identified approximately 3 kb upstream of the ESX promoter.
  • The EES demonstrated epithelial-specific enhancer activity, and its deletion abolished ESX gene transcription.
  • An EES-binding protein complex (EBC) was identified, with binding levels correlating to endogenous ESX levels and regulated by epithelial differentiation.

Conclusions:

  • The identified EES is a key regulatory element responsible for the epithelial-specific expression of ESX.
  • Understanding EES and EBC regulation provides insights into epithelial differentiation mechanisms.
  • This regulatory pathway may represent a novel therapeutic target for breast cancer intervention.